Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |